Pharmaceutical outsourcing-Global Market Status & Trend Report 2016-2026 Top 20 Countries Data
Report Summary
Pharmaceutical outsourcing-Global Market Status & Trend Report 2016-2026 Top 20 Countries Data offers a comprehensive analysis on Pharmaceutical outsourcing industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Pharmaceutical outsourcing 2016-2021, and development forecast 2022-2026
Main manufacturers/suppliers of Pharmaceutical outsourcing worldwide and market share by regions, with company and product introduction, position in the Pharmaceutical outsourcing market
Market status and development trend of Pharmaceutical outsourcing by types and applications
Cost and profit status of Pharmaceutical outsourcing, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Pharmaceutical outsourcing market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Pharmaceutical outsourcing industry.
The report segments the global Pharmaceutical outsourcing market as:
Global Pharmaceutical outsourcing Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2016-2026):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Pharmaceutical outsourcing Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2016-2026):
Raw Material Sourcing
Active Pharmaceutical Ingredient
Finished Drugs
Global Pharmaceutical outsourcing Market: Application Segment Analysis (Consumption Volume and Market Share 206-2026; Downstream Customers and Market Analysis)
Drug Discovery
Clinical Trials
Pre-Clinical Development
Biology Research
Global Pharmaceutical outsourcing Market: Manufacturers Segment Analysis (Company and Product introduction, Pharmaceutical outsourcing Sales Volume, Revenue, Price and Gross Margin):
ABC Laboratories
Aenova
Alkermes
Associates of Cape Cod
BioPharma Solutions
Catalent Pharma Solutions
Coldstream Laboratories
Covance
Cytovance Biologics
Dalton Pharma Services
DPT Laboratories
Emergent BioSolutions
Fresenius Kabi
Grand River Aseptic Manufacturing
Halo Pharmaceutical
IGI Laboratories
Lyophilization Technology
Metrics
Mikart
Patheon
Pillar5 Pharma
Velesco Pharma
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Pharmaceutical outsourcing-Global Market Status & Trend Report 2016-2026 Top 20 Countries Data offers a comprehensive analysis on Pharmaceutical outsourcing industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Pharmaceutical outsourcing 2016-2021, and development forecast 2022-2026
Main manufacturers/suppliers of Pharmaceutical outsourcing worldwide and market share by regions, with company and product introduction, position in the Pharmaceutical outsourcing market
Market status and development trend of Pharmaceutical outsourcing by types and applications
Cost and profit status of Pharmaceutical outsourcing, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Pharmaceutical outsourcing market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Pharmaceutical outsourcing industry.
The report segments the global Pharmaceutical outsourcing market as:
Global Pharmaceutical outsourcing Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2016-2026):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Pharmaceutical outsourcing Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2016-2026):
Raw Material Sourcing
Active Pharmaceutical Ingredient
Finished Drugs
Global Pharmaceutical outsourcing Market: Application Segment Analysis (Consumption Volume and Market Share 206-2026; Downstream Customers and Market Analysis)
Drug Discovery
Clinical Trials
Pre-Clinical Development
Biology Research
Global Pharmaceutical outsourcing Market: Manufacturers Segment Analysis (Company and Product introduction, Pharmaceutical outsourcing Sales Volume, Revenue, Price and Gross Margin):
ABC Laboratories
Aenova
Alkermes
Associates of Cape Cod
BioPharma Solutions
Catalent Pharma Solutions
Coldstream Laboratories
Covance
Cytovance Biologics
Dalton Pharma Services
DPT Laboratories
Emergent BioSolutions
Fresenius Kabi
Grand River Aseptic Manufacturing
Halo Pharmaceutical
IGI Laboratories
Lyophilization Technology
Metrics
Mikart
Patheon
Pillar5 Pharma
Velesco Pharma
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF PHARMACEUTICAL OUTSOURCING
1.1 Definition of Pharmaceutical outsourcing in This Report
1.2 Commercial Types of Pharmaceutical outsourcing
1.2.1 Raw Material Sourcing
1.2.2 Active Pharmaceutical Ingredient
1.2.3 Finished Drugs
1.3 Downstream Application of Pharmaceutical outsourcing
1.3.1 Drug Discovery
1.3.2 Clinical Trials
1.3.3 Pre-Clinical Development
1.3.4 Biology Research
1.4 Development History of Pharmaceutical outsourcing
1.5 Market Status and Trend of Pharmaceutical outsourcing 2016-2026
1.5.1 Global Pharmaceutical outsourcing Market Status and Trend 2016-2026
1.5.2 Regional Pharmaceutical outsourcing Market Status and Trend 2016-2026
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Pharmaceutical outsourcing 2016-2021
2.2 Sales Market of Pharmaceutical outsourcing by Regions
2.2.1 Sales Volume of Pharmaceutical outsourcing by Regions
2.2.2 Sales Value of Pharmaceutical outsourcing by Regions
2.3 Production Market of Pharmaceutical outsourcing by Regions
2.4 Global Market Forecast of Pharmaceutical outsourcing 2022-2026
2.4.1 Global Market Forecast of Pharmaceutical outsourcing 2022-2026
2.4.2 Market Forecast of Pharmaceutical outsourcing by Regions 2022-2026
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Pharmaceutical outsourcing by Types
3.2 Sales Value of Pharmaceutical outsourcing by Types
3.3 Market Forecast of Pharmaceutical outsourcing by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Pharmaceutical outsourcing by Downstream Industry
4.2 Global Market Forecast of Pharmaceutical outsourcing by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Pharmaceutical outsourcing Market Status by Countries
5.1.1 North America Pharmaceutical outsourcing Sales by Countries (2016-2021)
5.1.2 North America Pharmaceutical outsourcing Revenue by Countries (2016-2021)
5.1.3 United States Pharmaceutical outsourcing Market Status (2016-2021)
5.1.4 Canada Pharmaceutical outsourcing Market Status (2016-2021)
5.1.5 Mexico Pharmaceutical outsourcing Market Status (2016-2021)
5.2 North America Pharmaceutical outsourcing Market Status by Manufacturers
5.3 North America Pharmaceutical outsourcing Market Status by Type (2016-2021)
5.3.1 North America Pharmaceutical outsourcing Sales by Type (2016-2021)
5.3.2 North America Pharmaceutical outsourcing Revenue by Type (2016-2021)
5.4 North America Pharmaceutical outsourcing Market Status by Downstream Industry (2016-2021)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Pharmaceutical outsourcing Market Status by Countries
6.1.1 Europe Pharmaceutical outsourcing Sales by Countries (2016-2021)
6.1.2 Europe Pharmaceutical outsourcing Revenue by Countries (2016-2021)
6.1.3 Germany Pharmaceutical outsourcing Market Status (2016-2021)
6.1.4 UK Pharmaceutical outsourcing Market Status (2016-2021)
6.1.5 France Pharmaceutical outsourcing Market Status (2016-2021)
6.1.6 Italy Pharmaceutical outsourcing Market Status (2016-2021)
6.1.7 Russia Pharmaceutical outsourcing Market Status (2016-2021)
6.1.8 Spain Pharmaceutical outsourcing Market Status (2016-2021)
6.1.9 Benelux Pharmaceutical outsourcing Market Status (2016-2021)
6.2 Europe Pharmaceutical outsourcing Market Status by Manufacturers
6.3 Europe Pharmaceutical outsourcing Market Status by Type (2016-2021)
6.3.1 Europe Pharmaceutical outsourcing Sales by Type (2016-2021)
6.3.2 Europe Pharmaceutical outsourcing Revenue by Type (2016-2021)
6.4 Europe Pharmaceutical outsourcing Market Status by Downstream Industry (2016-2021)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Pharmaceutical outsourcing Market Status by Countries
7.1.1 Asia Pacific Pharmaceutical outsourcing Sales by Countries (2016-2021)
7.1.2 Asia Pacific Pharmaceutical outsourcing Revenue by Countries (2016-2021)
7.1.3 China Pharmaceutical outsourcing Market Status (2016-2021)
7.1.4 Japan Pharmaceutical outsourcing Market Status (2016-2021)
7.1.5 India Pharmaceutical outsourcing Market Status (2016-2021)
7.1.6 Southeast Asia Pharmaceutical outsourcing Market Status (2016-2021)
7.1.7 Australia Pharmaceutical outsourcing Market Status (2016-2021)
7.2 Asia Pacific Pharmaceutical outsourcing Market Status by Manufacturers
7.3 Asia Pacific Pharmaceutical outsourcing Market Status by Type (2016-2021)
7.3.1 Asia Pacific Pharmaceutical outsourcing Sales by Type (2016-2021)
7.3.2 Asia Pacific Pharmaceutical outsourcing Revenue by Type (2016-2021)
7.4 Asia Pacific Pharmaceutical outsourcing Market Status by Downstream Industry (2016-2021)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Pharmaceutical outsourcing Market Status by Countries
8.1.1 Latin America Pharmaceutical outsourcing Sales by Countries (2016-2021)
8.1.2 Latin America Pharmaceutical outsourcing Revenue by Countries (2016-2021)
8.1.3 Brazil Pharmaceutical outsourcing Market Status (2016-2021)
8.1.4 Argentina Pharmaceutical outsourcing Market Status (2016-2021)
8.1.5 Colombia Pharmaceutical outsourcing Market Status (2016-2021)
8.2 Latin America Pharmaceutical outsourcing Market Status by Manufacturers
8.3 Latin America Pharmaceutical outsourcing Market Status by Type (2016-2021)
8.3.1 Latin America Pharmaceutical outsourcing Sales by Type (2016-2021)
8.3.2 Latin America Pharmaceutical outsourcing Revenue by Type (2016-2021)
8.4 Latin America Pharmaceutical outsourcing Market Status by Downstream Industry (2016-2021)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Pharmaceutical outsourcing Market Status by Countries
9.1.1 Middle East and Africa Pharmaceutical outsourcing Sales by Countries (2016-2021)
9.1.2 Middle East and Africa Pharmaceutical outsourcing Revenue by Countries (2016-2021)
9.1.3 Middle East Pharmaceutical outsourcing Market Status (2016-2021)
9.1.4 Africa Pharmaceutical outsourcing Market Status (2016-2021)
9.2 Middle East and Africa Pharmaceutical outsourcing Market Status by Manufacturers
9.3 Middle East and Africa Pharmaceutical outsourcing Market Status by Type (2016-2021)
9.3.1 Middle East and Africa Pharmaceutical outsourcing Sales by Type (2016-2021)
9.3.2 Middle East and Africa Pharmaceutical outsourcing Revenue by Type (2016-2021)
9.4 Middle East and Africa Pharmaceutical outsourcing Market Status by Downstream Industry (2016-2021)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF PHARMACEUTICAL OUTSOURCING
10.1 Global Economy Situation and Trend Overview
10.2 Pharmaceutical outsourcing Downstream Industry Situation and Trend Overview
CHAPTER 11 PHARMACEUTICAL OUTSOURCING MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Pharmaceutical outsourcing by Major Manufacturers
11.2 Production Value of Pharmaceutical outsourcing by Major Manufacturers
11.3 Basic Information of Pharmaceutical outsourcing by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Pharmaceutical outsourcing Major Manufacturer
11.3.2 Employees and Revenue Level of Pharmaceutical outsourcing Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 PHARMACEUTICAL OUTSOURCING MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 ABC Laboratories
12.1.1 Company profile
12.1.2 Representative Pharmaceutical outsourcing Product
12.1.3 Pharmaceutical outsourcing Sales, Revenue, Price and Gross Margin of ABC Laboratories
12.2 Aenova
12.2.1 Company profile
12.2.2 Representative Pharmaceutical outsourcing Product
12.2.3 Pharmaceutical outsourcing Sales, Revenue, Price and Gross Margin of Aenova
12.3 Alkermes
12.3.1 Company profile
12.3.2 Representative Pharmaceutical outsourcing Product
12.3.3 Pharmaceutical outsourcing Sales, Revenue, Price and Gross Margin of Alkermes
12.4 Associates of Cape Cod
12.4.1 Company profile
12.4.2 Representative Pharmaceutical outsourcing Product
12.4.3 Pharmaceutical outsourcing Sales, Revenue, Price and Gross Margin of Associates of Cape Cod
12.5 BioPharma Solutions
12.5.1 Company profile
12.5.2 Representative Pharmaceutical outsourcing Product
12.5.3 Pharmaceutical outsourcing Sales, Revenue, Price and Gross Margin of BioPharma Solutions
12.6 Catalent Pharma Solutions
12.6.1 Company profile
12.6.2 Representative Pharmaceutical outsourcing Product
12.6.3 Pharmaceutical outsourcing Sales, Revenue, Price and Gross Margin of Catalent Pharma Solutions
12.7 Coldstream Laboratories
12.7.1 Company profile
12.7.2 Representative Pharmaceutical outsourcing Product
12.7.3 Pharmaceutical outsourcing Sales, Revenue, Price and Gross Margin of Coldstream Laboratories
12.8 Covance
12.8.1 Company profile
12.8.2 Representative Pharmaceutical outsourcing Product
12.8.3 Pharmaceutical outsourcing Sales, Revenue, Price and Gross Margin of Covance
12.9 Cytovance Biologics
12.9.1 Company profile
12.9.2 Representative Pharmaceutical outsourcing Product
12.9.3 Pharmaceutical outsourcing Sales, Revenue, Price and Gross Margin of Cytovance Biologics
12.10 Dalton Pharma Services
12.10.1 Company profile
12.10.2 Representative Pharmaceutical outsourcing Product
12.10.3 Pharmaceutical outsourcing Sales, Revenue, Price and Gross Margin of Dalton Pharma Services
12.11 DPT Laboratories
12.11.1 Company profile
12.11.2 Representative Pharmaceutical outsourcing Product
12.11.3 Pharmaceutical outsourcing Sales, Revenue, Price and Gross Margin of DPT Laboratories
12.12 Emergent BioSolutions
12.12.1 Company profile
12.12.2 Representative Pharmaceutical outsourcing Product
12.12.3 Pharmaceutical outsourcing Sales, Revenue, Price and Gross Margin of Emergent BioSolutions
12.13 Fresenius Kabi
12.13.1 Company profile
12.13.2 Representative Pharmaceutical outsourcing Product
12.13.3 Pharmaceutical outsourcing Sales, Revenue, Price and Gross Margin of Fresenius Kabi
12.14 Grand River Aseptic Manufacturing
12.14.1 Company profile
12.14.2 Representative Pharmaceutical outsourcing Product
12.14.3 Pharmaceutical outsourcing Sales, Revenue, Price and Gross Margin of Grand River Aseptic Manufacturing
12.15 Halo Pharmaceutical
12.15.1 Company profile
12.15.2 Representative Pharmaceutical outsourcing Product
12.15.3 Pharmaceutical outsourcing Sales, Revenue, Price and Gross Margin of Halo Pharmaceutical
12.16 IGI Laboratories
12.17 Lyophilization Technology
12.18 Metrics
12.19 Mikart
12.20 Patheon
12.21 Pillar5 Pharma
12.22 Velesco Pharma
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PHARMACEUTICAL OUTSOURCING
13.1 Industry Chain of Pharmaceutical outsourcing
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF PHARMACEUTICAL OUTSOURCING
14.1 Cost Structure Analysis of Pharmaceutical outsourcing
14.2 Raw Materials Cost Analysis of Pharmaceutical outsourcing
14.3 Labor Cost Analysis of Pharmaceutical outsourcing
14.4 Manufacturing Expenses Analysis of Pharmaceutical outsourcing
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Pharmaceutical outsourcing in This Report
1.2 Commercial Types of Pharmaceutical outsourcing
1.2.1 Raw Material Sourcing
1.2.2 Active Pharmaceutical Ingredient
1.2.3 Finished Drugs
1.3 Downstream Application of Pharmaceutical outsourcing
1.3.1 Drug Discovery
1.3.2 Clinical Trials
1.3.3 Pre-Clinical Development
1.3.4 Biology Research
1.4 Development History of Pharmaceutical outsourcing
1.5 Market Status and Trend of Pharmaceutical outsourcing 2016-2026
1.5.1 Global Pharmaceutical outsourcing Market Status and Trend 2016-2026
1.5.2 Regional Pharmaceutical outsourcing Market Status and Trend 2016-2026
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Pharmaceutical outsourcing 2016-2021
2.2 Sales Market of Pharmaceutical outsourcing by Regions
2.2.1 Sales Volume of Pharmaceutical outsourcing by Regions
2.2.2 Sales Value of Pharmaceutical outsourcing by Regions
2.3 Production Market of Pharmaceutical outsourcing by Regions
2.4 Global Market Forecast of Pharmaceutical outsourcing 2022-2026
2.4.1 Global Market Forecast of Pharmaceutical outsourcing 2022-2026
2.4.2 Market Forecast of Pharmaceutical outsourcing by Regions 2022-2026
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Pharmaceutical outsourcing by Types
3.2 Sales Value of Pharmaceutical outsourcing by Types
3.3 Market Forecast of Pharmaceutical outsourcing by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Pharmaceutical outsourcing by Downstream Industry
4.2 Global Market Forecast of Pharmaceutical outsourcing by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Pharmaceutical outsourcing Market Status by Countries
5.1.1 North America Pharmaceutical outsourcing Sales by Countries (2016-2021)
5.1.2 North America Pharmaceutical outsourcing Revenue by Countries (2016-2021)
5.1.3 United States Pharmaceutical outsourcing Market Status (2016-2021)
5.1.4 Canada Pharmaceutical outsourcing Market Status (2016-2021)
5.1.5 Mexico Pharmaceutical outsourcing Market Status (2016-2021)
5.2 North America Pharmaceutical outsourcing Market Status by Manufacturers
5.3 North America Pharmaceutical outsourcing Market Status by Type (2016-2021)
5.3.1 North America Pharmaceutical outsourcing Sales by Type (2016-2021)
5.3.2 North America Pharmaceutical outsourcing Revenue by Type (2016-2021)
5.4 North America Pharmaceutical outsourcing Market Status by Downstream Industry (2016-2021)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Pharmaceutical outsourcing Market Status by Countries
6.1.1 Europe Pharmaceutical outsourcing Sales by Countries (2016-2021)
6.1.2 Europe Pharmaceutical outsourcing Revenue by Countries (2016-2021)
6.1.3 Germany Pharmaceutical outsourcing Market Status (2016-2021)
6.1.4 UK Pharmaceutical outsourcing Market Status (2016-2021)
6.1.5 France Pharmaceutical outsourcing Market Status (2016-2021)
6.1.6 Italy Pharmaceutical outsourcing Market Status (2016-2021)
6.1.7 Russia Pharmaceutical outsourcing Market Status (2016-2021)
6.1.8 Spain Pharmaceutical outsourcing Market Status (2016-2021)
6.1.9 Benelux Pharmaceutical outsourcing Market Status (2016-2021)
6.2 Europe Pharmaceutical outsourcing Market Status by Manufacturers
6.3 Europe Pharmaceutical outsourcing Market Status by Type (2016-2021)
6.3.1 Europe Pharmaceutical outsourcing Sales by Type (2016-2021)
6.3.2 Europe Pharmaceutical outsourcing Revenue by Type (2016-2021)
6.4 Europe Pharmaceutical outsourcing Market Status by Downstream Industry (2016-2021)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Pharmaceutical outsourcing Market Status by Countries
7.1.1 Asia Pacific Pharmaceutical outsourcing Sales by Countries (2016-2021)
7.1.2 Asia Pacific Pharmaceutical outsourcing Revenue by Countries (2016-2021)
7.1.3 China Pharmaceutical outsourcing Market Status (2016-2021)
7.1.4 Japan Pharmaceutical outsourcing Market Status (2016-2021)
7.1.5 India Pharmaceutical outsourcing Market Status (2016-2021)
7.1.6 Southeast Asia Pharmaceutical outsourcing Market Status (2016-2021)
7.1.7 Australia Pharmaceutical outsourcing Market Status (2016-2021)
7.2 Asia Pacific Pharmaceutical outsourcing Market Status by Manufacturers
7.3 Asia Pacific Pharmaceutical outsourcing Market Status by Type (2016-2021)
7.3.1 Asia Pacific Pharmaceutical outsourcing Sales by Type (2016-2021)
7.3.2 Asia Pacific Pharmaceutical outsourcing Revenue by Type (2016-2021)
7.4 Asia Pacific Pharmaceutical outsourcing Market Status by Downstream Industry (2016-2021)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Pharmaceutical outsourcing Market Status by Countries
8.1.1 Latin America Pharmaceutical outsourcing Sales by Countries (2016-2021)
8.1.2 Latin America Pharmaceutical outsourcing Revenue by Countries (2016-2021)
8.1.3 Brazil Pharmaceutical outsourcing Market Status (2016-2021)
8.1.4 Argentina Pharmaceutical outsourcing Market Status (2016-2021)
8.1.5 Colombia Pharmaceutical outsourcing Market Status (2016-2021)
8.2 Latin America Pharmaceutical outsourcing Market Status by Manufacturers
8.3 Latin America Pharmaceutical outsourcing Market Status by Type (2016-2021)
8.3.1 Latin America Pharmaceutical outsourcing Sales by Type (2016-2021)
8.3.2 Latin America Pharmaceutical outsourcing Revenue by Type (2016-2021)
8.4 Latin America Pharmaceutical outsourcing Market Status by Downstream Industry (2016-2021)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Pharmaceutical outsourcing Market Status by Countries
9.1.1 Middle East and Africa Pharmaceutical outsourcing Sales by Countries (2016-2021)
9.1.2 Middle East and Africa Pharmaceutical outsourcing Revenue by Countries (2016-2021)
9.1.3 Middle East Pharmaceutical outsourcing Market Status (2016-2021)
9.1.4 Africa Pharmaceutical outsourcing Market Status (2016-2021)
9.2 Middle East and Africa Pharmaceutical outsourcing Market Status by Manufacturers
9.3 Middle East and Africa Pharmaceutical outsourcing Market Status by Type (2016-2021)
9.3.1 Middle East and Africa Pharmaceutical outsourcing Sales by Type (2016-2021)
9.3.2 Middle East and Africa Pharmaceutical outsourcing Revenue by Type (2016-2021)
9.4 Middle East and Africa Pharmaceutical outsourcing Market Status by Downstream Industry (2016-2021)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF PHARMACEUTICAL OUTSOURCING
10.1 Global Economy Situation and Trend Overview
10.2 Pharmaceutical outsourcing Downstream Industry Situation and Trend Overview
CHAPTER 11 PHARMACEUTICAL OUTSOURCING MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Pharmaceutical outsourcing by Major Manufacturers
11.2 Production Value of Pharmaceutical outsourcing by Major Manufacturers
11.3 Basic Information of Pharmaceutical outsourcing by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Pharmaceutical outsourcing Major Manufacturer
11.3.2 Employees and Revenue Level of Pharmaceutical outsourcing Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 PHARMACEUTICAL OUTSOURCING MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 ABC Laboratories
12.1.1 Company profile
12.1.2 Representative Pharmaceutical outsourcing Product
12.1.3 Pharmaceutical outsourcing Sales, Revenue, Price and Gross Margin of ABC Laboratories
12.2 Aenova
12.2.1 Company profile
12.2.2 Representative Pharmaceutical outsourcing Product
12.2.3 Pharmaceutical outsourcing Sales, Revenue, Price and Gross Margin of Aenova
12.3 Alkermes
12.3.1 Company profile
12.3.2 Representative Pharmaceutical outsourcing Product
12.3.3 Pharmaceutical outsourcing Sales, Revenue, Price and Gross Margin of Alkermes
12.4 Associates of Cape Cod
12.4.1 Company profile
12.4.2 Representative Pharmaceutical outsourcing Product
12.4.3 Pharmaceutical outsourcing Sales, Revenue, Price and Gross Margin of Associates of Cape Cod
12.5 BioPharma Solutions
12.5.1 Company profile
12.5.2 Representative Pharmaceutical outsourcing Product
12.5.3 Pharmaceutical outsourcing Sales, Revenue, Price and Gross Margin of BioPharma Solutions
12.6 Catalent Pharma Solutions
12.6.1 Company profile
12.6.2 Representative Pharmaceutical outsourcing Product
12.6.3 Pharmaceutical outsourcing Sales, Revenue, Price and Gross Margin of Catalent Pharma Solutions
12.7 Coldstream Laboratories
12.7.1 Company profile
12.7.2 Representative Pharmaceutical outsourcing Product
12.7.3 Pharmaceutical outsourcing Sales, Revenue, Price and Gross Margin of Coldstream Laboratories
12.8 Covance
12.8.1 Company profile
12.8.2 Representative Pharmaceutical outsourcing Product
12.8.3 Pharmaceutical outsourcing Sales, Revenue, Price and Gross Margin of Covance
12.9 Cytovance Biologics
12.9.1 Company profile
12.9.2 Representative Pharmaceutical outsourcing Product
12.9.3 Pharmaceutical outsourcing Sales, Revenue, Price and Gross Margin of Cytovance Biologics
12.10 Dalton Pharma Services
12.10.1 Company profile
12.10.2 Representative Pharmaceutical outsourcing Product
12.10.3 Pharmaceutical outsourcing Sales, Revenue, Price and Gross Margin of Dalton Pharma Services
12.11 DPT Laboratories
12.11.1 Company profile
12.11.2 Representative Pharmaceutical outsourcing Product
12.11.3 Pharmaceutical outsourcing Sales, Revenue, Price and Gross Margin of DPT Laboratories
12.12 Emergent BioSolutions
12.12.1 Company profile
12.12.2 Representative Pharmaceutical outsourcing Product
12.12.3 Pharmaceutical outsourcing Sales, Revenue, Price and Gross Margin of Emergent BioSolutions
12.13 Fresenius Kabi
12.13.1 Company profile
12.13.2 Representative Pharmaceutical outsourcing Product
12.13.3 Pharmaceutical outsourcing Sales, Revenue, Price and Gross Margin of Fresenius Kabi
12.14 Grand River Aseptic Manufacturing
12.14.1 Company profile
12.14.2 Representative Pharmaceutical outsourcing Product
12.14.3 Pharmaceutical outsourcing Sales, Revenue, Price and Gross Margin of Grand River Aseptic Manufacturing
12.15 Halo Pharmaceutical
12.15.1 Company profile
12.15.2 Representative Pharmaceutical outsourcing Product
12.15.3 Pharmaceutical outsourcing Sales, Revenue, Price and Gross Margin of Halo Pharmaceutical
12.16 IGI Laboratories
12.17 Lyophilization Technology
12.18 Metrics
12.19 Mikart
12.20 Patheon
12.21 Pillar5 Pharma
12.22 Velesco Pharma
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PHARMACEUTICAL OUTSOURCING
13.1 Industry Chain of Pharmaceutical outsourcing
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF PHARMACEUTICAL OUTSOURCING
14.1 Cost Structure Analysis of Pharmaceutical outsourcing
14.2 Raw Materials Cost Analysis of Pharmaceutical outsourcing
14.3 Labor Cost Analysis of Pharmaceutical outsourcing
14.4 Manufacturing Expenses Analysis of Pharmaceutical outsourcing
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
